Advancing Safe and Effective Radionuclide Therapy

The Dosimetry Core Unit (DCU) is a Netherlands-based consortium supporting clinical, translational, and preclinical dosimetry research in molecular radiotherapy.

Events

Mar 17, 2026
Summer Course: Basic Dosimetry and Radiobiology for Radionuclide Therapy
Open
Deadline: May 15, 2026
Professional education course by Radboud University focused on dosimetry and radiobiology for radionuclide therapy.
View event details and registration

Featured Publications

View all publications
  1. Chatzipapas, K. P., Papachristou, K., Visvikis, D., Incerti, S., Hazle, J. D., & Kagadis, G. C. (2025). In silico assessment of cellular damage from Lu-177, Ac-225, and Pb-212 therapeutic radionuclides. Medical Physics, 52(11), e70089. https://doi.org/https://doi.org/10.1002/mp.70089
  2. Wenker, S. T. M., van Lith, S. A. M., Tamborino, G., Konijnenberg, M. W., Bussink, J., & Heskamp, S. (2025). The potential of targeted radionuclide therapy to treat hypoxic tumor cells. Nuclear Medicine and Biology, 140–141, 108971. https://doi.org/10.1016/j.nucmedbio.2024.108971
  3. Chatzipapas, K. P., Tran, H. N., Dordevic, M., Sakata, D., Incerti, S., Visvikis, D., & Bert, J. (2024). Development of a novel computational technique to create DNA and cell geometrical models for Geant4-DNA. Physica Medica, 127, 104839. https://doi.org/https://doi.org/10.1016/j.ejmp.2024.104839

Contact

For collaborations, event participation, and scientific inquiries, contact the DCU team.
Email: dosimetry.nl@gmail.com